Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamín Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monréal, David Jiménez, Gregory Piazza, Sahil A. Parikh, Ajay J. Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, Harlan M. Krumholz, Gregory Y.H. Lip, Samuel Z. Goldhaber, Behnood Bikdeli
Topics & Concepts
MedicineAntithromboticRandomized controlled trialCoronavirus disease 2019 (COVID-19)Intensive care medicineClinical trialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Thrombosis2019-20 coronavirus outbreakPerspective (graphical)DiseaseInternal medicinePathologyInfectious disease (medical specialty)Computer scienceOutbreakArtificial intelligenceCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Venous Thromboembolism Diagnosis and Management